Complexo Hospitalario Universitario de Lugo
Care center
![Foto de Complexo Hospitalario Universitario de Lugo](/img/noimage.png)
![Foto de University of Parma](/img/noimage_org.png)
University of Parma
Parma, ItaliaPublications in collaboration with researchers from University of Parma (5)
2023
-
Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial
The Lancet, Vol. 401, Núm. 10379, pp. 821-832
-
Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial
Targeted Oncology, Vol. 18, Núm. 5, pp. 639-641
2020
-
Characteristics and treatment regimens across ERS SHARP severe asthma registries
European Respiratory Journal, Vol. 55, Núm. 1
2017
-
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis
American Journal of Human Genetics, Vol. 100, Núm. 1, pp. 64-74
2015
-
A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility
American Journal of Human Genetics, Vol. 96, Núm. 4, pp. 565-580